Oncotelic Therapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Oncotelic Therapeutics, Inc. (OTLC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 1.19 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-04-15
- Oncotelic Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2022-03-31 was 165.21M shares, a 175.03% increase year-over-year.
- Oncotelic Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-09-30 was 100.85M shares, a 126.54% increase year-over-year.
- Oncotelic Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-06-30 was 84.32M shares, a 219.73% increase year-over-year.
- Oncotelic Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-03-31 was 60.07M shares, a 79.54% increase year-over-year.
- Oncotelic Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 1.19M shares.
- Oncotelic Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 139.45M shares, a 225.21% increase from fiscal 2020.
- Oncotelic Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 42.88M shares, a 20.25% increase from fiscal 2019.
- Oncotelic Therapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 35.66M shares, a 14.42% increase from fiscal 2018.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | 1.19M shares 10-K · filed 2026-04-15 | |||||
| 2022-03-31 | 165.21M shares 10-Q · filed 2022-05-23 | |||||
| 2021-12-31 | 139.45M shares 10-K · filed 2022-04-15 | |||||
| 2021-09-30 | 100.85M shares 10-Q · filed 2021-11-22 | 100.85M shares 10-Q · filed 2021-11-22 | ||||
| 2021-06-30 | 84.32M shares 10-Q · filed 2021-08-20 | 84.32M shares 10-Q · filed 2021-08-20 | ||||
| 2021-03-31 | 60.07M shares 10-Q · filed 2022-05-23 | |||||
| 2020-12-31 | 42.88M shares 10-K · filed 2022-04-15 | |||||
| 2020-09-30 | 44.52M shares 10-Q · filed 2021-11-22 | 44.52M shares 10-Q · filed 2021-11-22 | ||||
| 2020-06-30 | 26.37M shares 10-Q · filed 2021-08-20 | 26.37M shares 10-Q · filed 2021-08-20 | 32.96M shares 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | 33.46M shares 10-Q · filed 2021-05-24 | |||||
| 2019-12-31 | 35.66M shares 10-K · filed 2021-04-15 | |||||
| 2019-09-30 | 35.66M shares 10-Q · filed 2020-11-16 | 35.66M shares 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | 33.46M shares 10-Q · filed 2020-08-14 | 36.69M shares 10-Q · filed 2019-08-19 | 36.69M shares 10-Q · filed 2020-08-14 | |||
| 2018-12-31 | 31.17M shares 10-K · filed 2020-05-14 | |||||
| 2018-09-30 | 31.17M shares 10-Q · filed 2019-11-19 | 31.17M shares 10-Q · filed 2019-11-19 | ||||
| 2018-06-30 | 2.86M shares 10-Q · filed 2019-08-19 | 31.85M shares 10-Q · filed 2019-08-19 |